PetMed Express (PETS) Stock Price, News & Analysis

Company Overview

PetMed Express, Inc. (NASDAQ: PETS) operates as an online retailer specializing in pet medications and related products. Founded in 1996 and based in Delray Beach, Florida, the company was one of the first to offer prescription and non-prescription pharmaceuticals for dogs and cats through its PetsWarehouse.com and 1-800-PETMED e-commerce platforms. Over the years, PetMed Express has expanded its product assortment to encompass parasite preventives, dermatology treatments, supplements, and health-related accessories, catering to the evolving needs of pet owners.

The company’s core offerings include FDA-approved prescription medications for chronic conditions such as arthritis, allergies, and heart disease, as well as popular over-the-counter products for flea, tick and heartworm control. In addition to pharmaceuticals, PetMed Express stocks food, treats, vitamins, grooming supplies, and other wellness items sourced from leading brands. The business model emphasizes convenience, allowing customers to upload veterinary prescriptions, set up recurring shipments for maintenance therapies and access online resources on pet health topics.

While PetMed Express primarily serves the United States, it maintains a presence in Canada through cross-border fulfillment partnerships and helps customers navigate import regulations for prescription products. The company leverages a vertically integrated distribution network, including its FDA-inspected warehouses and call center, to streamline order processing, ensure product authenticity and offer customer support. PetMed Express also invests in digital marketing initiatives, mobile app enhancements and telehealth pilot programs to strengthen client engagement and capture share of the growing online pet care market.

Founded and led by industry veteran Stephen M. Duerr, PetMed Express has adhered to a mission of improving pet health through accessible pet pharmacy solutions. The leadership team includes experienced professionals in logistics, quality assurance, regulatory affairs and information technology, underscoring the company’s commitment to compliance and customer satisfaction. Over more than two decades, PetMed Express has built brand recognition as a trusted resource for pet medications and wellness products.

Key Stats

• Today's Range: $3.17 to $3.35
• 50-Day Range: $3.24 to $4.19
• 52-Week Range: $2.90 to $6.85
• Volume: 120,396 shs
• Average Volume: 194,927 shs
• Market Capitalization: $65.89 million
• P/E Ratio: 319.32
• Dividend Yield: N/A
• Price Target: $3.35
• Consensus Rating: Reduce

PetMed Express Stock Analysis - MarketRank™

PetMed Express scored higher than 14% of companies evaluated by MarketBeat, and ranked 202nd out of 213 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.8 / 5
• Analyst Rating: Reduce

Consensus Rating

PetMed Express has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

PetMed Express has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -84.21%

Earnings Growth

Earnings for PetMed Express are expected to decrease by -84.21% in the coming year, from $0.19 to $0.03 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of PetMed Express is 319.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.26.

Price to Earnings Ratio vs. Sector

The P/E ratio of PetMed Express is 319.32, which means that it is trading at a more expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 29.81.

Price to Book Value per Share Ratio

PetMed Express has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.27% of the float of PetMed Express has been sold short.

Short Interest Ratio / Days to Cover

PetMed Express has a short interest ratio ("days to cover") of 9.5.

Change versus previous month

Short interest in PetMed Express has recently decreased by 4.29%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

PetMed Express does not currently pay a dividend.

Dividend Growth

PetMed Express does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of PetMed Express is 9,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on EPS estimates, PetMed Express will have a dividend payout ratio of 3,000.00% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

9.27% of the float of PetMed Express has been sold short.

Short Interest Ratio / Days to Cover

PetMed Express has a short interest ratio ("days to cover") of 9.5.

Change versus previous month

Short interest in PetMed Express has recently decreased by 4.29%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.37

News Sentiment

PetMed Express has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Retail/Wholesale companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for PetMed Express this week, compared to 3 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, PetMed Express insiders have sold 422.47% more of their company's stock than they have bought. Specifically, they have bought $38,305.00 in company stock and sold $200,133.00 in company stock.

Percentage Held by Insiders

Only 1.10% of the stock of PetMed Express is held by insiders.

Percentage Held by Institutions

73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PETS Stock Analysis - Frequently Asked Questions

How have PETS shares performed this year?

PetMed Express' stock was trading at $4.82 at the start of the year. Since then, PETS shares have decreased by 33.8% and is now trading at $3.19.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) announced its quarterly earnings results on Monday, February, 10th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.02. PetMed Express had a net margin of 0.14% and a trailing twelve-month return on equity of 0.37%.
Read the conference call transcript.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Meta Platforms (META), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Walt Disney (DIS), Ford Motor (F) and PayPal (PYPL).

Company Calendar

• Last Earnings: 2/10/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Retail/Wholesale
• Industry: INTERNET COMMERCE
• Sub-Industry: Internet Retail
• Current Symbol: NASDAQ:PETS
• CIK: 1040130
• Web: www.1800petmeds.com
• Phone: (561) 526-4444
• Fax: 561-526-4445
• Employees: 210
• Year Founded: 1996

Price Target and Rating

• Average Price Target for PetMed Express: $3.35
• High Price Target: $3.50
• Low Price Target: $3.20
• Potential Upside/Downside: +5.3%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.01
• Trailing P/E Ratio: 318.32
• Forward P/E Ratio: 16.74
• P/E Growth: N/A
• Net Income: -$7.46 million
• Net Margins: 0.14%
• Pretax Margin: 0.78%
• Return on Equity: 0.37%
• Return on Assets: 0.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.43
• Quick Ratio: 1.18

Sales & Book Value

• Annual Sales: $247.01 million
• Price / Sales: 0.27
• Cash Flow: $0.02 per share
• Price / Cash Flow: 145.67
• Book Value: $4.57 per share
• Price / Book: 0.70

Miscellaneous

• Outstanding Shares: 20,656,000
• Free Float: 20,429,000
• Market Cap: $65.69 million
• Optionable: Optionable
• Beta: 0.78